Author

L. Tu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

A. Hu· 1 shared A. Li· 1 shared A. W. Hewitt· 1 shared B. V. Bui· 1 shared C. Ma· 1 shared C.-L. Tseng· 1 shared D. Ling· 1 shared F. Huang· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Hu

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A potent human monoclonal antibody with pan-neutralizing activities directly dislocates S trimer of SARS-CoV-2 through binding both up and down forms of RBD

X. Wang, A. Hu, X. Chen, Y. Zhang, F. Yu, S. Yue, A. Li, J. Zhang, Z. Pan, Y. Yang, Y. Lin, L. Gao, J. Zhou, J. Zhao, F. Li, , L. Ye

This study identifies a potent human monoclonal antibody, 35B5, that neutralizes SARS-CoV-2 and its variants by targeting a conserved epitope on the RBD, offering a potential therapeutic and vaccine design strategy.

bioRxiv · Nov 29, 2021Immunology

TAK1 blockade as a therapy for retinal neovascularization

F.-L. Lin, J.-H. Wang, J. Chen, L. Zhu, Y.-F. Chuang, L. Tu, C. Ma, S. Lama, D. Ling, R. C.-B. Wong, A. W. Hewitt, C.-L. Tseng, B. V. Bui, P. van Wijngaarden, G. J. Dusting, , G.-S. Liu

This study investigates TAK1's role in retinal neovascularization and shows that inhibiting TAK1 reduces aberrant angiogenesis in a rat model.

bioRxiv · Jan 29, 2021Biochemistry